Quantification of the Underlying Mechanisms and Relationships Among Cancer, Metastasis, and Differentiation and Development

Overview

Journal Front Genet

Date 2020 Mar 21

PMID 32194614

Citations 11

Authors

Chong Yu

Qiong Liu

Cong Chen

Jin Wang

Affiliations

Soon will be listed here.

Abstract

Recurrence and metastasis have been regarded as two of the greatest obstacles to cancer therapy. Cancer stem cells (CSCs) contribute to cancer development, with the distinctive features of recurrence and resistance to popular treatments such as drugs and chemotherapy. In addition, recent discoveries suggest that the epithelial mesenchymal transition (EMT) is an essential process in normal embryogenesis and tissue repair, as well as being a required step in cancer metastasis. Although there are many indications of the connections between metastasis and stem cells, these have often been studied separately or at most bi-laterally, not in an integrated way. In this study, we aimed to explore the global mechanisms and interrelationships among cancer, development, and metastasis, which are currently poorly understood. First, we constructed a core gene regulatory network containing specific genes and microRNAs of CSCs, EMT, and cancer. We uncovered seven distinct states emerging from the underlying landscape, denoted normal, premalignant, cancer, stem cell, CSC, lesion, and hyperplasia. Given the biological definition of each state, we also discuss the metastasis ability of each state. We show how and which types of cells can be transformed to a cancer state, and the connections among cancer, CSCs, and EMT. The barrier height and flux of the kinetic paths are explored to quantify how and which cells switch stochastically between the states. Our landscape model provides a quantitative approach to reveal the global mechanisms of cancer, development, and metastasis.

Citing Articles

General relationship of local topologies, global dynamics, and bifurcation in cellular networks.

Hu Q, Tang R, He X, Wang R NPJ Syst Biol Appl. 2024; 10(1):135.

PMID: 39557967 PMC: 11573990. DOI: 10.1038/s41540-024-00470-1.

Single-cell transcriptomics: background, technologies, applications, and challenges.

Duhan L, Kumari D, Naime M, Parmar V, Chhillar A, Dangi M Mol Biol Rep. 2024; 51(1):600.

PMID: 38689046 DOI: 10.1007/s11033-024-09553-y.

Insights into the cell fate decision-making processes from chromosome structural reorganizations.

Chu X, Wang J Biophys Rev (Melville). 2024; 3(4):041402.

PMID: 38505520 PMC: 10914134. DOI: 10.1063/5.0107663.

Non-canonical DNA structures in the human ribosomal DNA.

Smirnov E, Molinova P, Chmurciakova N, Vacik T, Cmarko D Histochem Cell Biol. 2023; 160(6):499-515.

PMID: 37750997 DOI: 10.1007/s00418-023-02233-1.

Data mining and mathematical models in cancer prognosis and prediction.

Yu C, Wang J Med Rev (2021). 2023; 2(3):285-307.

PMID: 37724193 PMC: 10388766. DOI: 10.1515/mr-2021-0026.

References

Strauss R, Li Z, Liu Y, Beyer I, Persson J, Sova P . Analysis of epithelial and mesenchymal markers in ovarian cancer reveals phenotypic heterogeneity and plasticity. PLoS One. 2011; 6(1):e16186. PMC: 3021543. DOI: 10.1371/journal.pone.0016186. View

Mani S, Guo W, Liao M, Eaton E, Ayyanan A, Zhou A . The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008; 133(4):704-15. PMC: 2728032. DOI: 10.1016/j.cell.2008.03.027. View

Wang J, Xu L, Wang E . Potential landscape and flux framework of nonequilibrium networks: robustness, dissipation, and coherence of biochemical oscillations. Proc Natl Acad Sci U S A. 2008; 105(34):12271-6. PMC: 2527901. DOI: 10.1073/pnas.0800579105. View

Yu C, Wang J . A Physical Mechanism and Global Quantification of Breast Cancer. PLoS One. 2016; 11(7):e0157422. PMC: 4943646. DOI: 10.1371/journal.pone.0157422. View

Li C, Wang J . Quantifying the Landscape for Development and Cancer from a Core Cancer Stem Cell Circuit. Cancer Res. 2015; 75(13):2607-18. DOI: 10.1158/0008-5472.CAN-15-0079. View

Wang J, Zhang K, Xu L, Wang E . Quantifying the Waddington landscape and biological paths for development and differentiation. Proc Natl Acad Sci U S A. 2011; 108(20):8257-62. PMC: 3100956. DOI: 10.1073/pnas.1017017108. View

Chaffer C, Brueckmann I, Scheel C, Kaestli A, Wiggins P, Rodrigues L . Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. Proc Natl Acad Sci U S A. 2011; 108(19):7950-5. PMC: 3093533. DOI: 10.1073/pnas.1102454108. View

Morel A, Lievre M, Thomas C, Hinkal G, Ansieau S, Puisieux A . Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One. 2008; 3(8):e2888. PMC: 2492808. DOI: 10.1371/journal.pone.0002888. View

Liu S, Ginestier C, Charafe-Jauffret E, Foco H, Kleer C, Merajver S . BRCA1 regulates human mammary stem/progenitor cell fate. Proc Natl Acad Sci U S A. 2008; 105(5):1680-5. PMC: 2234204. DOI: 10.1073/pnas.0711613105. View

10.

Pastushenko I, Brisebarre A, Sifrim A, Fioramonti M, Revenco T, Boumahdi S . Identification of the tumour transition states occurring during EMT. Nature. 2018; 556(7702):463-468. DOI: 10.1038/s41586-018-0040-3. View

11.

Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, Coradini D . Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res. 2005; 65(13):5506-11. DOI: 10.1158/0008-5472.CAN-05-0626. View

12.

Xu L, Zhang K, Wang J . Exploring the mechanisms of differentiation, dedifferentiation, reprogramming and transdifferentiation. PLoS One. 2014; 9(8):e105216. PMC: 4136825. DOI: 10.1371/journal.pone.0105216. View

13.

Yang P, Du C, Kwan M, Liang S, Zhang G . The impact of p53 in predicting clinical outcome of breast cancer patients with visceral metastasis. Sci Rep. 2013; 3:2246. PMC: 3718193. DOI: 10.1038/srep02246. View

14.

Pavlova N, Thompson C . The Emerging Hallmarks of Cancer Metabolism. Cell Metab. 2016; 23(1):27-47. PMC: 4715268. DOI: 10.1016/j.cmet.2015.12.006. View

15.

Jolly M, Boareto M, Huang B, Jia D, Lu M, Ben-Jacob E . Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis. Front Oncol. 2015; 5:155. PMC: 4507461. DOI: 10.3389/fonc.2015.00155. View

16.

Takahashi K, Yamanaka S . Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006; 126(4):663-76. DOI: 10.1016/j.cell.2006.07.024. View

17.

Kreso A, OBrien C, van Galen P, Gan O, Notta F, Brown A . Variable clonal repopulation dynamics influence chemotherapy response in colorectal cancer. Science. 2012; 339(6119):543-8. PMC: 9747244. DOI: 10.1126/science.1227670. View

18.

Morel A, Hinkal G, Thomas C, Fauvet F, Courtois-Cox S, Wierinckx A . EMT inducers catalyze malignant transformation of mammary epithelial cells and drive tumorigenesis towards claudin-low tumors in transgenic mice. PLoS Genet. 2012; 8(5):e1002723. PMC: 3359981. DOI: 10.1371/journal.pgen.1002723. View

19.

Scheel C, Weinberg R . Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links. Semin Cancer Biol. 2012; 22(5-6):396-403. PMC: 6220425. DOI: 10.1016/j.semcancer.2012.04.001. View

20.

Rizzino A . Concise review: The Sox2-Oct4 connection: critical players in a much larger interdependent network integrated at multiple levels. Stem Cells. 2013; 31(6):1033-9. PMC: 3664101. DOI: 10.1002/stem.1352. View